COVID-19 Delayed Cancer Treatment, Diagnoses
Restrictions in access to care during the COVID-19 pandemic caused disruptions in the treatment and diagnoses of cancer and other conditions.
Read MorePosted by Andy Lundin | Dec 6, 2021 | Cancer, Covid 19 |
Restrictions in access to care during the COVID-19 pandemic caused disruptions in the treatment and diagnoses of cancer and other conditions.
Read MorePosted by Andy Lundin | Dec 6, 2021 | Covid 19, Immunoassay Reagents & test Kits |
The discovery of the Omicron variant resulted in increased surveillance of COVID-19 in the U.S., which includes a thorough analysis of current test samples.
Read MorePosted by Andy Lundin | Dec 6, 2021 | Covid 19, Immunoassay Reagents & test Kits |
The PCR-based test from Seegene recognizes four SARS-CoV-2 genes and five notable mutations on the spike protein.
Read MorePosted by Andy Lundin | Dec 6, 2021 | Covid 19, Molecular Diagnostics |
How the U.S. has addressed genomic sequencing research played a large role in the country’s ability to to track the evolution of COVID-19.
Read MorePosted by Andy Lundin | Dec 3, 2021 | Covid 19, Rapid Assays |
The LumiraDx SARS-CoV-2 RNA STAR Complete has been authorized by FDA for emergency use under an EUA for use by authorized laboratories.
Read More